These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32643390)

  • 1. Exosomes as mediators and biomarkers in fibrosis.
    Qin XJ; Zhang JX; Wang RL
    Biomark Med; 2020 Jun; 14(8):697-712. PubMed ID: 32643390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
    Hwang S; Yang YM
    Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review.
    Wang J; Yue BL; Huang YZ; Lan XY; Liu WJ; Chen H
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.
    Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X
    FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis.
    Negrete-García MC; de Jesús Ramos-Abundis J; Alvarado-Vasquez N; Montes-Martínez E; Montaño M; Ramos C; Sommer B
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular or Exosomal microRNAs Associated with CCN Gene Expression in Liver Fibrosis.
    Chen L; Brigstock DR
    Methods Mol Biol; 2017; 1489():465-480. PubMed ID: 27734397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
    Cheng L; Wu S; Zhang K; Qing Y; Xu T
    J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The versatile roles and clinical implications of exosomal mRNAs and microRNAs in cancer.
    Tang S; Yu S; Cheng J; Zhang Y; Huang X
    Int J Biol Markers; 2020 Jun; 35(2):3-19. PubMed ID: 32389046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome.
    Chun-Yan L; Zi-Yi Z; Tian-Lin Y; Yi-Li W; Bao L; Jiao L; Wei-Jun D
    Exp Mol Pathol; 2018 Oct; 105(2):223-228. PubMed ID: 30121168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of extracellular vesicles in physiology and disease.
    Hanayama R
    J Biochem; 2021 Mar; 169(2):135-138. PubMed ID: 33231609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl
    Broermann A; Schmid R; Gabrielyan O; Sakowski M; Eisele C; Keller S; Wolff M; Baum P; Stierstorfer B; Huber J; Krämer BK; Hocher B; Streicher R; Delić D
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the effect of exosomes from different cells on liver fibrosis.
    Hu X; Ge Q; Zhang Y; Li B; Cheng E; Wang Y; Huang Y
    Biomed Pharmacother; 2023 May; 161():114415. PubMed ID: 36812711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
    Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
    Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.
    Zehra M; Curry JC; Pillai SS; Lakhani HV; Edwards CE; Sodhi K
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis.
    Tang X; Leng M; Tang W; Cai Z; Yang L; Wang L; Zhang Y; Guo J
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.
    Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X
    Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications.
    Xu YX; Pu SD; Li X; Yu ZW; Zhang YT; Tong XW; Shan YY; Gao XY
    Pharmacol Res; 2022 Apr; 178():106135. PubMed ID: 35192956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal microRNAs in diabetic heart disease.
    Chandrasekera D; Katare R
    Cardiovasc Diabetol; 2022 Jul; 21(1):122. PubMed ID: 35778763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of exosome function in the CNS: implications for neurodegeneration.
    Properzi F; Ferroni E; Poleggi A; Vinci R
    Swiss Med Wkly; 2015; 145():w14204. PubMed ID: 26561744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.